In Depth 16 Nov 2023
Meet the ‘biotech mafia’: how specialized biotech VC firms are dominating industry funding once again
Between 2020 and 2022 - largely due to the biotech innovations that came about by the COVID-19 pandemic - there was an influx of generalist investors in the biotech industry,…